RAGE anticorps (N-Term)
Aperçu rapide pour RAGE anticorps (N-Term) (ABIN3043529)
Antigène
Voir toutes RAGE (AGER) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 91-120, N-Term
-
Fonction
- Anti-RAGE/AGER Antibody
-
Séquence
- IQDEGIFRCQ AMNRNGKETK SNYRVRVYQI
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Attributs du produit
- Anti-RAGE/AGER Antibody (ABIN3043529). Tested in IHC, WB applications. This antibody reacts with Human, Mouse, Rat. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human RAGE, different from the related mouse and rat sequences by six amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Immunohistochemistry (Paraffin-embedded Section), 0.5-1 μg/mL, Human, Mouse, Rat
Western blot, 0.1-0.5 μg/mL, Human, Rat
-
Commentaires
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB, supported by ABIN921231 in IHC(P).
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
-
-
-
: "Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus." dans: Annals of dermatology, Vol. 29, Issue 1, pp. 121-123, (2017) (PubMed).
: "Neuroprotective effect of salvianolate lyophilized injection against cerebral ischemia in type 1 diabetic rats." dans: BMC complementary and alternative medicine, Vol. 17, Issue 1, pp. 258, (2017) (PubMed).
: "Epigallocatechin-3-gallate attenuates neointimal hyperplasia in a rat model of carotid artery injury by inhibition of high mobility group box 1 expression." dans: Experimental and therapeutic medicine, Vol. 14, Issue 3, pp. 1975-1982, (2017) (PubMed).
: "Ethyl pyruvate attenuated coxsackievirus B3-induced acute viral myocarditis by suppression of HMGB1/RAGE/NF-ΚB pathway." dans: SpringerPlus, Vol. 5, pp. 215, (2016) (PubMed).
: "Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway." dans: Cardiovascular diabetology, Vol. 12, pp. 37, (2013) (PubMed).
: "Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats." dans: Journal of medicinal food, Vol. 16, Issue 7, pp. 577-86, (2013) (PubMed).
: "Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia." dans: Brain research, Vol. 1321, pp. 143-51, (2010) (PubMed).
: "Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression." dans: Neuroscience letters, Vol. 471, Issue 3, pp. 152-6, (2010) (PubMed).
-
: "Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus." dans: Annals of dermatology, Vol. 29, Issue 1, pp. 121-123, (2017) (PubMed).
-
- RAGE (AGER) (Advanced Glycosylation End Product-Specific Receptor (AGER))
-
Autre désignation
- AGER
-
Sujet
-
Synonyms: Advanced glycosylation end product-specific receptor,Receptor for advanced glycosylation end products,AGER,RAGE,
Tissue Specificity: Endothelial cells.
Background: The receptor for advanced glycation end products (RAGE) is a multi-ligand member of the immunoglobulin superfamily of cell surface molecules. It interacts with distinct molecules implicated in homeostasis, development and inflammation, and certain diseases such as diabetes and Alzheimer's disease. RAGE is also a central cell surface receptor for amphoterin and EN-RAGE. And RAGE is associated with sustained NF-kappaB activation in the diabetic microenvironment and has a central role in sensory neuronal dysfunction. Moreover, RAGE propagates cellular dysfunction in several inflammatory disorders and diabetes, and it also functions as an endothelial adhesion receptor promoting leukocyte recruitment.
Sequence Similarities: Contains 2 Ig-like C2-type (immunoglobulin-like) domains.
-
Poids moléculaire
- 45-58 kDa
-
ID gène
- 177
-
UniProt
- Q15109
-
Pathways
- Carbohydrate Homeostasis, Toll-Like Receptors Cascades, Smooth Muscle Cell Migration, S100 Proteins
Antigène
-